Immunocore Holdings (IMCR) Long-Term Deferred Tax: 2022-2025
Historic Long-Term Deferred Tax for Immunocore Holdings (IMCR) over the last 2 years, with Sep 2025 value amounting to $14.3 million.
- Immunocore Holdings' Long-Term Deferred Tax rose 13.19% to $14.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.3 million, marking a year-over-year increase of 13.19%. This contributed to the annual value of $14.8 million for FY2024, which is 34.79% up from last year.
- Immunocore Holdings' Long-Term Deferred Tax amounted to $14.3 million in Q3 2025, which was up 1.82% from $14.1 million recorded in Q2 2025.
- In the past 5 years, Immunocore Holdings' Long-Term Deferred Tax ranged from a high of $14.8 million in Q4 2024 and a low of $5.1 million during Q4 2022.
- For the 3-year period, Immunocore Holdings' Long-Term Deferred Tax averaged around $12.8 million, with its median value being $13.4 million (2024).
- Data for Immunocore Holdings' Long-Term Deferred Tax shows a peak YoY skyrocketed of 114.27% (in 2023) over the last 5 years.
- Quarterly analysis of 4 years shows Immunocore Holdings' Long-Term Deferred Tax stood at $5.1 million in 2022, then surged by 114.27% to $11.0 million in 2023, then spiked by 34.79% to $14.8 million in 2024, then increased by 13.19% to $14.3 million in 2025.
- Its Long-Term Deferred Tax was $14.3 million in Q3 2025, compared to $14.1 million in Q2 2025 and $14.4 million in Q1 2025.